Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up.
about
Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015)Mesenchymal stem cells (MSCs) as skeletal therapeutics - an updateMicromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regenerationThe role of purinergic receptors in stem cell differentiationInduced pluripotent stem cell potential in medicine, specifically focused on reproductive medicineEnhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21.Are nestin-positive mesenchymal stromal cells a better source of cells for CNS repair?Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathwaysMeta-analysis of the effect of mesenchymal stem cell transplantation on vascular remodeling after carotid balloon injury in animal models.HGF Gene Modification in Mesenchymal Stem Cells Reduces Radiation-Induced Intestinal Injury by Modulating Immunity.Dual isotope simultaneous imaging to evaluate the effects of intracoronary bone marrow-derived mesenchymal stem cells on perfusion and metabolism in canines with acute myocardial infarction.Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro.Clusterin/Akt Up-Regulation Is Critical for GATA-4 Mediated Cytoprotection of Mesenchymal Stem Cells against Ischemia InjuryTNF-α enhances vascular cell adhesion molecule-1 expression in human bone marrow mesenchymal stem cells via the NF-κB, ERK and JNK signaling pathways.Mesenchymal stem cells for treatment of aortic aneurysmsDevices for stem cell isolation and delivery: current need for drug discovery and cell therapy.Post-myocardial infarct inflammation and the potential role of cell therapy.Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications.Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical Trials.Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction.Bone marrow mesenchymal stem cells ameliorate lung injury through anti-inflammatory and antibacterial effect in COPD mice.Myocardial Regeneration via Progenitor Cell-Derived Exosomes.Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease.Effect of heme oxygenase-1 transduced bone marrow mesenchymal stem cells on damaged intestinal epithelial cells in vitro.Recent Progress in Stem Cell Modification for Cardiac Regeneration.Isolation, characterization and cardiac differentiation of human thymus tissue derived mesenchymal stromal cells.Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.The use of stem cells in ischemic heart disease treatment
P2860
Q26748751-1F692B92-11DD-4D33-977F-420CA7BE12B8Q26753086-1662F36F-FB8F-493E-9F36-89982E16291BQ26765166-6EEC67F9-4200-4400-BDB1-C38DA2A69242Q26768507-3070E8CE-1D2D-49BF-925C-E7B5994C2713Q28083057-15622298-0B52-4783-B0A0-B1049295E35BQ33722181-BD768B3F-34F8-4E8B-B697-34CFCF8627F4Q33757255-354132E0-C80E-45A5-966B-9A2329C389DEQ35144219-4B524636-E223-459C-B4F6-D22AEC483E43Q35219587-7CF17E0C-D8DF-4F7D-9B08-AD4F8498A055Q35560905-BFF02080-D9C7-4F4D-A661-6B67305C2B01Q35802937-35830EC4-8639-4E36-A443-3C3EB3173507Q35926017-4539CCF9-19F7-4A1A-B2C7-B3A2350D94C1Q35952100-734F9D03-FDE6-4081-A326-CAE6531F089AQ37032444-0CD7D18F-E909-48FD-80AF-A66B01996307Q38234556-BF33B589-20C5-47BB-BCF2-BACE71BEFDF2Q38300442-DDB36DE4-4554-499A-9171-505CB86B0531Q38316469-29C844D8-8838-4110-ACA6-3030D362B0AEQ38610604-9095F6DF-28E3-4141-AE1B-1301D9254697Q38777091-FFE71B79-9472-4982-9E3B-9884C93BE948Q38874116-2924C488-87E4-47CC-B911-4AF786A91B03Q47137130-E7B254FA-E9C8-40D3-9481-4DE858DF1EA2Q47808641-CA71D3AF-8770-4A36-B1CA-ADE625739185Q48247352-3E7A440F-CD51-4693-B300-F83E9BFFDD0FQ50677671-068ADC0E-F6DA-4F76-B21B-B20F765874BAQ51135492-C0023558-F2F5-4177-86DD-E19B49BE17ABQ52657125-8030880E-7AC2-4E7C-9275-FE4B999D4E19Q52980476-CC6AC181-C966-4295-BF0E-27B01B1CA8EFQ53116345-33AF50B6-1AC8-4DAA-A489-E4344C5083E8Q57494730-23CE87C2-C8CC-4C9E-95E1-63F0E82ADD7B
P2860
Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intramyocardial injection of a ...... fe up to 5 years of follow-up.
@en
Intramyocardial injection of a ...... fe up to 5 years of follow-up.
@nl
type
label
Intramyocardial injection of a ...... fe up to 5 years of follow-up.
@en
Intramyocardial injection of a ...... fe up to 5 years of follow-up.
@nl
prefLabel
Intramyocardial injection of a ...... fe up to 5 years of follow-up.
@en
Intramyocardial injection of a ...... fe up to 5 years of follow-up.
@nl
P2093
P2860
P1476
Intramyocardial injection of a ...... fe up to 5 years of follow-up.
@en
P2093
Douwe E Atsma
Georgette E Hoogslag
Helene Roelofs
Helèn Boden
Imad Al Younis
Jaap Jan Zwaginga
Jan van Ramshorst
Martin J Schalij
Matthijs A Velders
Petra Dibbets-Schneider
P2860
P2888
P304
P356
10.1007/S12265-013-9507-7
P407
P577
2013-08-28T00:00:00Z